Walleye Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-184,966
Closed -$1.84M 4328
2025
Q4
$1.84M Buy
184,966
+150,297
+434% +$1.44M 0.01% 1943
2025
Q3
$310K Buy
34,669
+24,080
+227% +$223K ﹤0.01% 2987
2025
Q2
$99.9K Buy
+10,589
New +$93.4K ﹤0.01% 3772
2024
Q2
Sell
-122,023
Closed -$1.4M 5530
2024
Q1
$1.4M Sell
122,023
-1,275
-1% -$10.8K ﹤0.01% 2262
2023
Q4
$899K Buy
+123,298
New +$972K ﹤0.01% 2442
2022
Q2
Sell
-23,557
Closed -$378K 2318
2022
Q1
$378K Buy
+23,557
New +$424K 0.01% 1164

Other funds holding AHCO

Walleye Capital's AHCO Position: Q1 2026 in Review

Walleye Capital sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 184,966 shares — an estimated $1.84M sold.

Walleye Capital first reported a position in AHCO in Q1 2022 and held it in 6 quarters. The position peaked at $1.84M in Q4 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Walleye Capital reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 184,966 AdaptHealth shares in Q1 2026, an estimated $1.84M.
  • Walleye Capital first reported a position in AdaptHealth in Q1 2022 and held it in 6 quarters.
  • Walleye Capital's AdaptHealth position peaked at $1.84M in Q4 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.